BioDelivery Sciences International Inc logo

BDSI - BioDelivery Sciences International Inc News Story

$3.2 -0.2  -5.3%

Last Trade - 8:03pm

Small Cap
Market Cap £244.0m
Enterprise Value £220.3m
Revenue £112.0m
Position in Universe 4013th / 6855

BRIEF-Biodelivery Sciences enters revenue sharing deal with Arius Pharmaceuticals and Meda AB

Wed 28th January, 2015 9:37pm
Jan 28 (Reuters) - BioDelivery Sciences International Inc  BDSI.O : 
 * Entered into a definitive assignment and revenue sharing agreement with arius 
   pharmaceuticals, inc and meda ab 
 * Agreement relating to certain licensing rights for the co's onsolis (fentanyl 
   buccal soluble film) product 
 * Meda to transfer rights to authorizations, right to seek such 
   Canadian and Mexican marketing authorizations back to co 
 * Source text for Eikon  ID:nEOL48dFhW  
 * Further company coverage  BDSI.O   
 ((Bengaluru Newsroom; +1 646 223 8780))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.